Kids Safe and Smokefree (KiSS)



Status:Completed
Conditions:Smoking Cessation, Smoking Cessation, Tobacco Consumers
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - Any
Updated:8/10/2018
Start Date:March 2012
End Date:June 2016

Use our guide to learn which trials are right for you!

Pediatrician Advice, Family Counseling & SHS Reduction for Underserved Children

The study's primary aim is to test the hypothesis that an intervention integrating pediatric
clinic-level quality improvement with home-level behavioral counseling (CQI+BC) will result
in greater reductions in child cotinine (a biomarker of secondhand smoke exposure) and
reported cigarettes exposed/day than a clinic-level quality improvement plus attention
control intervention (CQI+A). A secondary aim is to test the hypothesis that relative to
CQI+A, CQI+BC will result in higher cotinine-verified, 7-day point prevalence quit rate among
parents.

Child secondhand smoke exposure (SHSe) is a significant public health problem that has been
linked to asthma, acute respiratory illnesses, otitis, and SIDS, and is associated with
increased risk of cancers, cardiovascular disease, and behavior problems. This project will
test the effectiveness of a comprehensive multilevel intervention to reduce young children's
SHSe in minority and medically underserved communities known to have the highest SHSe-related
morbidity and mortality risk. First, we will provide a clinic-level quality improvement (CQI)
intervention to improve the care of pediatric patients with SHSe in four pediatric clinics in
North and West Philadelphia. We will then randomize eligible parents visiting the CQI clinics
into either a home-level behavioral counseling intervention (CQI+BC) or a home-level
attention control intervention (CQI+A). In addition to clinic-level intervention, CQI+BC
provides personalized, behavioral counseling with intensive skills training and support where
SHSe occurs (in the home), as well as systems navigation to facilitate access to and
effective use of reimbursable nicotine replacement therapy and smoking cessation medication.
Participants will complete assessments at pre-treatment, 3-month end of treatment, and
12-month follow-up.

Inclusion Criteria:

- at least 18 years of age

- English-speaking

- parent or legal guardian of child under 11 years old who lives with him/her

- daily smoker

Exclusion Criteria:

- non-nicotine drug dependence

- psychiatric disturbance (bipolar, schizophrenia, psychosis)

- pregnant

- inadequate health literacy
We found this trial at
4
sites
Philadelphia, Pennsylvania 19134
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19104
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
1801 N Broad St
Philadelphia, Pennsylvania 19122
(215) 204-7000
Temple University Temple University is many things to many people. A place to pursue life's...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19140
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials